Clinical trials for glaucoma neuroprotection are not impossible

Research output: Contribution to journalArticle

Abstract

PURPOSE OF REVIEW: To discuss issues that affect development of new glaucoma treatments known as neuroprotection. RECENT FINDINGS: There are barriers to neuroprotection trials for glaucoma. SUMMARY: With design features discussed in the review, neuroprotection trials can be effectively carried out.

Original languageEnglish (US)
Pages (from-to)144-154
Number of pages11
JournalCurrent Opinion in Ophthalmology
Volume23
Issue number2
DOIs
StatePublished - Mar 2012

Fingerprint

Glaucoma
Clinical Trials
Neuroprotection

Keywords

  • Clinical trial
  • Glaucoma
  • Neuroprotection

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Clinical trials for glaucoma neuroprotection are not impossible. / Quigley, Harry A.

In: Current Opinion in Ophthalmology, Vol. 23, No. 2, 03.2012, p. 144-154.

Research output: Contribution to journalArticle

@article{e593ed482d4b4f33ab46f2e3657598bf,
title = "Clinical trials for glaucoma neuroprotection are not impossible",
abstract = "PURPOSE OF REVIEW: To discuss issues that affect development of new glaucoma treatments known as neuroprotection. RECENT FINDINGS: There are barriers to neuroprotection trials for glaucoma. SUMMARY: With design features discussed in the review, neuroprotection trials can be effectively carried out.",
keywords = "Clinical trial, Glaucoma, Neuroprotection",
author = "Quigley, {Harry A}",
year = "2012",
month = "3",
doi = "10.1097/ICU.0b013e32834ff490",
language = "English (US)",
volume = "23",
pages = "144--154",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Clinical trials for glaucoma neuroprotection are not impossible

AU - Quigley, Harry A

PY - 2012/3

Y1 - 2012/3

N2 - PURPOSE OF REVIEW: To discuss issues that affect development of new glaucoma treatments known as neuroprotection. RECENT FINDINGS: There are barriers to neuroprotection trials for glaucoma. SUMMARY: With design features discussed in the review, neuroprotection trials can be effectively carried out.

AB - PURPOSE OF REVIEW: To discuss issues that affect development of new glaucoma treatments known as neuroprotection. RECENT FINDINGS: There are barriers to neuroprotection trials for glaucoma. SUMMARY: With design features discussed in the review, neuroprotection trials can be effectively carried out.

KW - Clinical trial

KW - Glaucoma

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=84857236328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857236328&partnerID=8YFLogxK

U2 - 10.1097/ICU.0b013e32834ff490

DO - 10.1097/ICU.0b013e32834ff490

M3 - Article

C2 - 22249238

AN - SCOPUS:84857236328

VL - 23

SP - 144

EP - 154

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 2

ER -